Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-3.24/5.75
|
|
Enterprise Value
22.65B
|
| Balance Sheet |
|
Book Value Per Share
-5.51
|
| Cash Flow |
|
Cash Flow Yield
0.69
|
| Income Statement |
|
Total Revenue
10.27B
|
|
Operating Revenue Per Share
27.49
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
|
Business Description
|
|||
| Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reportsrevenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment. |

5.335 
